pharma · Non-Muscle Invasive Bladder Urothelial Carcinoma · Nasopharyngeal Cancinoma (NPC)
Chongqing Daxin Pharmaceutical
Chongqing Claruvis Pharmaceutical Co.,
Chongqing Daxin Pharmaceutical clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Chongqing, CN HQ
5 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Chongqing, CN
- Employees
- 5
- Programs
- 2
- Drugs
- 6
- Patents
- 0
Chongqing Daxin Pharmaceutical projects
1 ClinicalTrials.gov programs sponsored by Chongqing Daxin Pharmaceutical.
Chongqing Daxin Pharmaceutical has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Chongqing Daxin Pharmaceutical have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.